Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
5.53
+0.04 (0.73%)
At close: Apr 28, 2026, 4:00 PM EDT
5.62
+0.09 (1.62%)
After-hours: Apr 28, 2026, 7:23 PM EDT
Valneva SE Market Cap
Valneva SE has a market cap or net worth of $491.15 million as of April 28, 2026. Its market cap has decreased by -13.84% in one year.
Market Cap
491.15M
Enterprise Value
605.43M
1-Year Change
-13.84%
Ranking
Category
Stock Price
$5.53
Market Cap Chart
Since the IPO on June 3, 2014, Valneva SE's market cap has increased from $450.94M to $491.15M, an increase of 8.92%. That is a compound annual growth rate of 0.72%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 4D Molecular Therapeutics | 479.88M |
| Candel Therapeutics | 476.11M |
| Armata Pharmaceuticals | 473.30M |
| Prelude Therapeutics | 472.60M |
| Larimar Therapeutics | 471.63M |
| Aura Biosciences | 466.73M |
| Contineum Therapeutics | 463.34M |
| Ginkgo Bioworks Holdings | 458.09M |